Lilly files petition with D.C. federal appeals court for rehearing before full court June 13. The federal appellate court upheld Barr's patent challenge to Prozac May 30 (1"The Pink Sheet" June 4, p. 21)
You may also be interested in...
Barr expects to launch its generic fluoxetine before October, the company said, following a federal appellate court decision upholding its patent challenge to Lilly's Prozac.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials